2.1999

1.38% -0.0401

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $2.1999, with a volume of 136.09K. It is down -1.38% in the last 24 hours and down -27.57% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$2.24

Open:

$2.21

24h Volume:

136.09K

Relative Volume:

0.25

Market Cap:

$200.36M

Revenue:

$25.14M

Net Income/Loss:

$-21.57M

P/E Ratio:

-8.1478

EPS:

-0.27

Net Cash Flow:

$-12.23M

1W Performance:

-18.78%

1M Performance:

-27.57%

6M Performance:

+8.29%

1Y Performance:

+5.70%

1-Day Range:

$2.12

$2.2317

1-Week Range:

$2.12

$2.89

52-Week Range:

$1.54

$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1129)

Industry

Medical Instruments & Supplies (56)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2025-03-03

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	2.20	209.05M	25.14M	-21.57M	-12.23M	-0.27
ISRG Intuitive Surgical Inc	556.52	200.47B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	192.59	55.33B	21.84B	1.68B	2.55B	5.8322
ALC Alcon Inc	77.57	38.61B	10.19B	1.05B	1.39B	2.1065
RMD Resmed Inc	249.20	36.80B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	263.12	19.18B	2.96B	487.70M	344.00M	6.6758

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

04:56 AM

Is Stereotaxis Inc. stock attractive for growth fundsPortfolio Profit Report & High Yield Equity Trading Tips - newser.com

04:56 AM

04:22 AM

How Stereotaxis Inc. stock correlates with oil marketsPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com

04:22 AM

03:50 AM

How rising interest rates impact Stereotaxis Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com

03:50 AM

01:39 AM

Stereotaxis Inc. stock momentum explainedWeekly Trend Summary & Community Driven Trade Alerts - newser.com

01:39 AM

Nov 13, 2025

What technical models suggest about Stereotaxis Inc.’s comebackMarket Trend Summary & Consistent Income Trade Ideas - newser.com

Nov 13, 2025

STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics - sharewise.com

Nov 13, 2025

Why Stereotaxis Inc. stock could see breakout soonWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com

Nov 13, 2025

How strong is Stereotaxis Inc. stock balance sheet2025 Price Targets & Safe Entry Zone Tips - newser.com

Nov 13, 2025

Stereotaxis, Inc. (AMEX:STXS) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 13, 2025

FDA clearances: Fujifilm Sonosite, Stereotaxis, Adaptix, Aiomega - Modern Healthcare News

Nov 13, 2025

Can Stereotaxis Inc. stock retain market dominanceShort Setup & Long Hold Capital Preservation Plans - newser.com

Nov 13, 2025

Why Stereotaxis Inc. stock could outperform in 2025July 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com

Nov 13, 2025

Using AI based signals to follow Stereotaxis Inc.Market Sentiment Report & AI Forecast Swing Trade Picks - newser.com

Nov 13, 2025

Nov 12, 2025

Will Stereotaxis Inc. stock maintain growth storyWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com

Nov 12, 2025

Stereotaxis, Inc. SEC 10-Q Report - TradingView

Nov 12, 2025

Biggest stock movers Wednesday: AMD, ALC, and more (NYSE:STXS) - Seeking Alpha

Nov 12, 2025

Is Stereotaxis Inc. stock trading near support levels2025 Price Action Summary & AI Based Trade Execution Alerts - newser.com

Nov 12, 2025

Stereotaxis (STXS) Shares Drop After Wider Loss and Revenue Miss - GuruFocus

Nov 12, 2025

Stereotaxis nets FDA clearance for redesigned surgical robot - Yahoo Finance

Nov 12, 2025

Stereotaxis shares drop after Q3 loss widens, GenesisX limited launch underway (STXS:NYSE) - Seeking Alpha

Nov 12, 2025